Stability of BIS with Schnider or modified Marsh effect-site targeted infusions: As you like it, or much ado about nothing?
Although commercial target-controlled infusion (TCI) systems have been available since the late 1990s1 and have facilitated safe and accurate administration of propofol in more than 90 countries,2 there remain areas of uncertainty and controversy.3
By submitting manuscripts to SAJAA, authors of original articles are assigning copyright to the SA Society of Anaesthesiologists. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAJAA for educational and research purposes without obtaining permission.
The work is licensed under a Creative Commons Attribution-Non-Commercial Works 4.0 South Africa License. The SAJAA does not hold itself responsible for statements made by the authors.